Nature Communications (Feb 2022)
Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo
Abstract
Gambiense human African trypanosomiasis has been targeted for elimination of transmission by 2030. Here, the authors assess the cost-effectiveness of elimination strategies in the Democratic Republic of the Congo and find that those which lead to elimination of transmission might also be considered cost-effective by conventional thresholds.